Clinical Trials Browser

Phase 3 × Melanoma × peginterferon alfa-2b × Clear all

NCT00221702 2010-10-13

EADO

Phase 3 Completed

Melanoma, Neoplasm Metastasis, Drug-Related Side Effects and Adverse Reactions